Crenezumab

DB11959InvestigationalProtein Based Therapies

Crenezumab has been used in trials studying the treatment of Alzheimer's Disease.

Mechanism: Pharmacologically active on Amyloid-beta precursor protein
Curator reviewed
Code names: MABT5102A

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

5Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Crenezumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.